cardiovascular pathology Flashcards

atherosclerosis: explain the pathology, pathophysiology, and clinical features of atherosclerosis

1
Q

define atherosclerosis

A

outcome of a permanently activated endothelium, causing formation of plaques within walls of large arteries, potentially causing thrombosis or occlusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

modifiable risk factors of atherosclerosis

A

smoking, lipid intake, blood pressure, diabetes, obesity, sedentary lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

non-modifiable risk factors of atherosclerosis

A

age, sex, genetic background

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

agents which activate endothelium in atherogenesis

A

smoking, viruses, toxins, mechanical stress (turbulent flow), inflammation, hypertension, OxLDL (carried to arteries), high glucose (diabetes), ageing, oxidative stress, hypercholesterolaemia, sex hormonal imbalance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

epidemiology of atherosclerosis

A

statins and antihypertensives mean obesity is driving factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LDL structure

A

lipid monolayer and docking apolipoproteins, with cargo fat (triglycerides and cholesterol esters)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

location of atherosclerosis

A

branch points of arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why does atherosclerosis occur at branch points

A

turbulent, not laminar, flow is present, so speed changes magnitude and direction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why does laminar flow not normally cause atherosclerosis (3)

A

activates KLF2/4 transcription factors to upregulate eNOS and anti-thrombotic and anti-inflammatory factors; also promotes nitric oxide production and inhibition of smooth muscle cell proliferation; downregulates DNA methyltransferases to allow continued demethylation of anti-atherotic gene promoter regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

why can turbulent flow cause atherosclerosis (6)

A

activates NK-kappaB for pro-inflammatory effects; upregulates DNMT to hypermethalate which repress anti-therotic genes; promotes coagulation, leukocyte adhesion, smooth muscle cell proliferation, endothelial apoptosis and reduced nitric oxide production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the 6 protective effects of nitric oxide on vascular endothelium

A

dilates blood vessels, reduces platelet activation, inhibits monocyte adhesion, reduces proliferation of smooth muscle cells in vessel wall, reduces release of superoxide radicals, reduces oxidation of LDL cholesterol (plaque)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does blood flow regulate gene expression

A

transcription factors selectively activated by laminar (e.g. eNOS for NO production) or turbulent (e.g. NF-KB) flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

blood flow regulation of endothelial epigenetic pathways

A

mechanosensors sense blood flow and cause changes in transcription by regulating chromatin (epigenetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

3 stages of pathogenesis of atherosclerosis

A

endothelial dysfunction, fatty streak formation, advanced complicated lesion formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

summary of endothelial dysfunction

A

endothelium in large vessels receive chronic stimuli of inflammation increase, increasing permeability and causing leukocyte accumulation under activated endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

summary of fatty streak formation

A

lipids get stuck under more permeable endothelium, binding to proteoglycans and becoming oxidised, before engulfment by macrophages, forming foam cells (fatty streaks)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

summary of advanced complicated lesion formation

A

other chronic processes such as macrophage accumulation, necrosis, senescence and angiogenesis cause an advanced complicated lesion to form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what blood vessels does leukocyte recruitment occur in normaly vs in atherosclerosis

A

normally affects post-capillary venules by contact inhibition, but in atherosclerosis it affects large arteries, as all stimuli activate endothelium in wrong place

19
Q

define contact inhibition and how does this contribute to formation of endothelial junctions

A

when cells in monolayer touch they stop proliferating and enter senescence; when leukocytes need to enter tissue they squeeze through these junctions in capillaries, but this is not possible in thick arteries due to layers of smooth muscle

20
Q

what is the effect of increased endothelial permeability in major arteries

A

leakage of plasma proteins (including lipoproteins) through junctions into subendothelial space, as well as oedema

21
Q

leukocyte recruitment in atherosclerosis: effect on monocytes

A

monocytes stuck between endothelium and smooth wall mature into macrophages

22
Q

leukocyte recruitment in atherosclerosis: how do leukocytes pass through endothelium when there is an inflammatory trigger (captured by intra-vital microscopy)

A

leukocytes roll, but when inflammatory trigger become activated; adhesion molecules on surface bind to leukocytes and adhesion strengthens; leukocyte flattens and spreads out, then migrates through tight junctions in endothelium (para or transcellular)

23
Q

outcome and fate of lipoproteins entering endothelium

A

lipoprotein pass through endothelium and are oxidised; macrophages present in subendothelial space then consume the lipoproteins and become foam cells, forming a fatty streak

24
Q

subtypes of macrophage scavenger receptors

25
macrophage scavenger receptor subtype A
CD204, bind oxLDL, dead cells and gram +ve bacteria to cause inflammation and destruction
26
macrophage scavenger receptor subtype B
CD36, bind oxLDL, malaria parasites and dead cells for safe clearance and reverse cholesterol transport
27
5 macrophage actions
generate free radicals to oxidise LDL, phagocytose modified lipoproteins, express cytokine mediators to recruit monocytes, express chemo-attractants and growth factors, express metalloproteinases
28
macrophages that express cytokine mediators to recruit monocytes
chemokines attract monocytes, cytokines activate endothelial cell adhesion molecules
29
macrophages that express chemo-attractants and growth factors
platelet-derived growth factor and transforming growth factor B for wound healing release complementary protein growth factors to recruit muscle cells and stimulate proliferation
30
fate of macrophages and effect of metalloproteinases
die and release pools of fat, forming necrotic core which causes fibrous thickening - if insufficient, family of enzymes that activate each other by proteolysis to degrade collagen (need zinc), degrading wall of plaque
31
outcome of ruptured plaque
fibrous cap becomes so thin that will break and rupture, allowing necrotic core to contact blood and cause thrombus formation
32
characteristics of a vulnerable cap
large, soft, eccentric lipid-rich necrotic core with increased smooth muscle cell apoptosis, reduced muscle/collagen content, thin fibrous cap, infiltrate of activate macrophages expressing metalloproteinases
33
define angiogenesis
formation of new vessels by sprouting from existing vessels
34
what 3 physiological functions is angiogenesis essential for
embyronic development, menstrual cycle, wound healing
35
what is the most powerful trigger for angiogenesis
hypoxia (e.g. caused by atheroclerosis)
36
how does angiogenesis contribute to atherosclerosis
promotes plaque growth
37
how does angiogenesis aid in atherosclerosis
prevents damage post-ischaemia
38
define cellular senescence and contribution to atherosclerosis
growth arrest that halts proliferation of ageing and/or damaged cells (e.g. protective defence against cancer); pro-inflammatory and so contribute to atherosclerosis
39
two main methods of protecting endothelium and preventing atherosclerosis
promote anti-pathways or prevent pro-pathways (e.g. anti-inflammatory)
40
what type of toxin is resveratol and what does this mean
hormetic toxin (in lower doses it has a protective effects on cardiovascular diseases, but at high doses it has cytotoxic effects)
41
what factors can influence atheroprotective genes
novel therapies, statins, diet, exercise, haemodynamics, hormonal balance, epigenetics, miRNAs
42
outcome of expression of atheroprotective genes
production of a vasoprotective endothelial phenotype which contributes to vascular homeostasis
43
atherosclerosis window of opportunity
lifestyle changes and risk factor management during intermediate/advanced lesion stage
44
clinical interventions of atherosclerosis
catheter based interventions, revascularisation surgery and treatment of heart failure/attacks